Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based “combo” nanoagent together with pd-l1 blockade in reversing multidrug resistance

HIGHLIGHTS

• who: Weixi Jiang from the Department of Ultrasound, Chongqing Key Laboratory of Ultrasound University, Chongqing, Peopleu2019s Republic of China have published the research work: Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based u201ccombou201d nanoagent together with PD-L1 blockade in reversing multidrug resistance, in the Journal: (JOURNAL)
• what: This work shows a significant enhancement in therapeutic efficacy against MDR cells and syngeneic tumors by using multiple MDR reversing strategies compared to an equivalent dose of free paclitaxel.
• how: The significance of the data was analyzed according to the one . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.